The US Bankruptcy Court granted an order for the joint administration of the Chapter 11 bankruptcy cases of Timber Pharmaceuticals, Inc. and its affiliate on November 21, 2023. The affiliate include BioPharmX, Inc. The cases would be jointly administered for administrative and procedural purposes. Timber Pharmaceuticals, Inc. has been designated as the lead debtor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -50.00% | -50.00% | -91.67% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-91.67% | 971K | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- BPC Stock
- TMBR Stock
- News Trex Wind-down, Inc.
- Motion for Joint Administration Approved for Timber Pharmaceuticals, Inc.